Navigation Links
Piccolo in Medical News

Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009

... comparable quarter. * Medical reagent disc sales of 467,000 units, up 48% over last year's comparable quarter. * Record sales of piccolo chemistry analyzers of 242 units, up 2% over last year's comparable quarter. * Sales of VetScan chemistry analyzers of 403 units, up 18% o...

Abaxis Point-of-Care Test Panels Gain FDA CLIA-Waived Status

...hen used by healthcare professionals in conjunction with the Piccolo(R) and piccolo Xpress(TM) point-of-care analyzers. As a result of their new waived status...ne of the most commonly conducted tests in the United States. "The piccolo Xpress has enabled us to cost-effectively improve patient care while increa...

Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008

... million, up 17% over last year's comparable quarter. -- Medical market sales of $6.0 million, up 29% over last year's comparable quarter. -- piccolo instrument sales of 238 units, up 45% over last year's comparable quarter. -- Veterinary hematology instrument sales of 301 units, up 44% over ...

Abaxis Announces First Ever CLIA-Waived Comprehensive Metabolic Panel

...d waived status by the FDA when used in conjunction with the Piccolo(R) and piccolo Xpress(TM) point-of-care analyzers for the medical market. "With these imp...iccolo analyzers can achieve lab-accurate results at the point of care. The piccolo analyzer and the complement of available CLIA waived diagnostic tests now b...

Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers

... manufacturing point-of-care blood chemistry analysis systems, announced today the launch of the Kidney Check Panel to be used in conjunction with the piccolo xpress(TM) point of care analyzer. The new Kidney Check Panel was designed specifically for imaging and radiology centers in the United States to det...
Piccolo in Biological Technology

EMD Biosciences partners with European biotech company

... TAP to optimize and validate EMDs products on the piccolo system, TAP's fully automated system for recombinant protein production. The piccolo system, a technology for assay development and pro...pplying key reagents from the EMD portfolio to the piccolo system will allow scientists to immediately use th...
Other Tags
(Date:7/9/2014)... in policing injection drug users in Russia might ... , A study, conducted by researchers from Boston ... collaboration with St. Petersburg Pavlov State University, sought ... the health outcomes of a cohort of HIV-positive ... Those who were arrested by police were more ...
(Date:7/9/2014)... French . By ... including brain structure and function, personality, life experiences and genetics, ... to develop binge drinking within the next two years. Impulsivity, ... as life events and a family history of drug use ... not the child had had a single drink at age ...
(Date:7/9/2014)... extinctions around the world have been linked to ... research from the National Institute for Mathematical and ... may also contribute. , In a series ... causes severe hemorrhage of internal organs in frogs, ... frogs if they are exposed to the virus ...
(Date:7/9/2014)... and Infectious Diseases (NIAID), part of the National ... trial of CRS3123, an investigational oral antibiotic intended ... difficile ) infection. CRS3123 (previously known as REP3123) ... growth while sparing normal intestinal bacteria. , The ... healthy men and women ages 18 to 45 ...
(Date:7/9/2014)... on prescription labels handed out by pharmacists may ... taking medication, according to new research by the ... for the Blind)., The study, published recently in ... labels on prescription medications dispensed by pharmacies do ... , By simply following recommended guidelines for font ...
Breaking Medicine News(10 mins):Health News:BU researchers relate arrests with HIV risk environment 2Health News:What drives a child to abuse alcohol? 2Health News:Study predicts ranavirus as potential new culprit in amphibian extinctions 2Health News:NIH launches Phase I clinical trial of novel drug to treat Clostridium difficile infection 2Health News:Most prescription labels fail to meet guidelines, risking dosage errors 2
(Date:7/9/2014)... candidate developed by researchers at the NIH,s ... and its collaborators to treat sickle cell ... BioScience business. The drug candidate, Aes-103, is ... underlying molecular mechanism of sickle cell disease. ... activities required for regulatory approval and commercialization. ...
(Date:7/9/2014)... southern Europe are less fit in terms of ... European peers. Moreover, southern adolescents are more obese ... fat than those from the centre-north of Europe. ... from an ambitious study conducted by scientists from ... in collaboration with 25 other European research groups. ...
(Date:7/9/2014)... yield big savings, if they are used in ... the Brigham and Women,s Hospital and coauthors analyzed ... savingshigh-cost patients; readmissions; triage; decompensation (when a patient,s ... a disease affects multiple organ systems. They suspect ... current costs associated with all six scenarios will ...
Breaking Biology News(10 mins):First drug candidate from NIH program acquired by biopharmaceutical company 2First drug candidate from NIH program acquired by biopharmaceutical company 3First drug candidate from NIH program acquired by biopharmaceutical company 4Adolescents from southern Europe are less fit and more obese than central-northern European peers 2The impact of big data on health care: Health Affairs' July issue 2
Other Contents